Prediction of outcome of extracorporeal shock wave lithotripsy in the management of ureteric calculi.
The present study was designed to evaluate the clinical outcome of using extracorporeal shock wave lithotripsy (ESWL) in the treatment of ureteric calculi and to establish a predictive model for the stone-free rate in patients receiving the treatment. A total of 831 patients with ureteric calculi were accepted in this study. Several parameters, including stone site, stone number, stone size, history of urolithiasis, renal colic, hydronephrosis, and double-J ureteric stent, were analyzed using univariate and multivariate analyses. A prediction model was established based on the logistic regression analysis of the significant factors, and the goodness-of-fit of the model was evaluated by employing the Hosmer-Lemeshow test. At a 3-month follow-up after ESWL treatment, the overall stone-free rate was 96.8% (804/831) with no serious complications being found, while the treatment failed in 3.2% (27/831) of the patients. Five factors, including stone number, stone size, history of urolithiasis, renal colic, and double-J ureteric stent contributed significantly to the clinical outcome of the ESWL treatment. The prediction model had a sensitivity and overall accuracy of 99.8 and 96.9%, respectively. The results show that ESWL remains an effective method for treating ureteric calculi. The prediction model established in this study could be used as a method for estimating prognosis in patients following ESWL treatment.
Wang
Mingqing
M
Centre of Urology, Nankai Hospital, Tianjin, 300100, People's Republic of China.
Shi
Qiduo
Q
Wang
Xuguang
X
Yang
Kun
K
Yang
Rui
R
D000328:Adult; D005260:Female; D006801:Humans; D006869:Hydronephrosis / Q000628:therapy; D008096:Lithotripsy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D056844:Renal Colic / Q000628:therapy; D015607:Stents; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014463:Ultrasonography; D014513:Ureter / Q000000981:diagnostic imaging / Q000601:surgery; D053039:Ureterolithiasis / Q000628:therapy*; D052878:Urolithiasis / Q000628:therapy
Ir J Med Sci. 1993 Sep;162(9):348-50
8262757
J Endourol. 2003 May;17(4):201-5
12816580
J Endourol. 1996 Dec;10(6):501-5
8972781
Hinyokika Kiyo. 1991 Dec;37(12):1633-7
1785386
BJU Int. 2007 Aug;100(2):392-5
17433030
J Urol. 1989 Mar;141(3 Pt 2):782-9
2645437
J Urol. 2004 Jul;172(1):175-9
15201765
World J Urol. 1993;11(1):54-8
8490668
J Urol. 1998 Mar;159(3):676-82
9474124
Urol Clin North Am. 1997 Feb;24(1):59-70
9048852
J Urol. 2003 Oct;170(4 Pt 1):1097-100
14501700
Eur Urol. 2005 Jun;47(6):855-9
15925083
Scand J Urol Nephrol. 2003;37(5):413-8
14594691
J Urol. 2003 May;169(5):1679-81
12686807
J Urol. 2006 Oct;176(4 Pt 1):1453-6; discussion 1456-7
16952658
BJU Int. 2005 Nov;96(7):1145
16225548
Eur Urol. 2007 Aug;52(2):318-20
17397991
Br J Urol. 1992 Sep;70(3):252-7
1422683
Br J Urol. 1994 May;73(5):487-93
8012768
J Endourol. 2005 Sep;19(7):768-73
16190825
Int Urol Nephrol. 2008;40(1):23-9
17647086
BJU Int. 1999 Nov;84(7):770-4
10532969
Int Urol Nephrol. 2007;39(1):85-9
17268897
J Urol. 1996 Sep;156(3):903-5; discussion 906
8709359
J Urol. 1997 Nov;158(5):1915-21
9334635
Scand J Urol Nephrol. 2002;36(3):209-12
12201937